Stockreport

Atossa Therapeutics updates protocol for breast cancer treatment trial [Yahoo! Finance]

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com
PDF in women with estrogen receptor positive (ER+) / human epidermal growth factor receptor 2 negative (HER2-) breast cancer. The study is assessing the combination regime [Read more]